Y10S 530/00
Chemistry: natural resins or derivatives
Official title: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Y10S530/00 (Chemistry: natural resins or derivatives) appears on 7,234 US grants and 2,454 published applications in this corpus.
Search patents in Y10S- Granted patents
- 7,234
- Published applications
- 2,454
- Assignees
- 2,342
- Inventors
- 10,197
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 81 | 0 |
| 1977 | 92 | 0 |
| 1978 | 112 | 0 |
| 1979 | 76 | 0 |
| 1980 | 111 | 0 |
| 1981 | 105 | 0 |
| 1982 | 128 | 0 |
| 1983 | 121 | 0 |
| 1984 | 180 | 0 |
| 1985 | 154 | 0 |
| 1986 | 112 | 0 |
| 1987 | 168 | 0 |
| 1988 | 183 | 0 |
| 1989 | 261 | 0 |
| 1990 | 245 | 0 |
| 1991 | 219 | 0 |
| 1992 | 238 | 0 |
| 1993 | 232 | 0 |
| 1994 | 199 | 0 |
| 1995 | 208 | 0 |
| 1996 | 221 | 0 |
| 1997 | 311 | 0 |
| 1998 | 417 | 0 |
| 1999 | 395 | 0 |
| 2000 | 326 | 0 |
| 2001 | 270 | 37 |
| 2002 | 233 | 228 |
| 2003 | 202 | 864 |
| 2004 | 151 | 208 |
| 2005 | 118 | 206 |
| 2006 | 196 | 150 |
| 2007 | 286 | 116 |
| 2008 | 204 | 100 |
| 2009 | 123 | 99 |
| 2010 | 115 | 97 |
| 2011 | 106 | 58 |
| 2012 | 85 | 75 |
| 2013 | 47 | 48 |
| 2014 | 52 | 30 |
| 2015 | 56 | 39 |
| 2016 | 29 | 24 |
| 2017 | 18 | 23 |
| 2018 | 19 | 14 |
| 2019 | 8 | 10 |
| 2020 | 10 | 8 |
| 2021 | 6 | 11 |
| 2022 | 1 | 2 |
| 2023 | 2 | 2 |
| 2024 | 0 | 1 |
| 2025 | 2 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- Y10S 530/827Proteins from mammals or birds2,167
- Y10S 530/82Proteins from microorganisms1,569
- Y10S 530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof1,220
- Y10S 530/806Antigenic peptides or proteins873
- Y10S 530/808Materials and products related to genetic engineering or hybrid or fused cell650
- Y10S 530/866Involving immunoglobulin or antibody fragment601
- Y10S 530/868Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance379
- Y10S 530/855Proteins from animals other than mammals or birds336
All 18 subgroupsShow fewer
- Y10S 530/807Hapten conjugated with peptide or protein302
- Y10S 530/863Involving igm216
- Y10S 530/86Renin inhibitors144
- Y10S 530/861Involving igg3, igg4, iga, or igy133
- Y10S 530/867Involving immunoglobulin or antibody produced via recombinant dna technology124
- Y10S 530/80Antihypertensive peptides104
- Y10S 530/802Chromogenic or luminescent peptides91
- Y10S 530/862Involving ige or igd72
- Y10S 530/801Peptide sweetners59
- Y10S 530/859Waste, waste material, refuse or sludge43
Recent patents
- Metal-binding protein and use thereof9 Dec 2025US 12,492,451 B2The Penn State Research Foundation
- Nutrient intake amount estimation system, nutrient intake amount estimation method, nutrient intake amount estimation device, storage medium, and nutrient intake amount output method25 Mar 2025US 12,260,950 B2Toto Ltd.
- GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis31 Oct 2023US 11,801,293 B2Children's Hospital & Research Center at Oakland
- Method of treating autoimmune inflammatory crohn's disease28 Mar 2023US 11,612,636 B2Actinobac Biomed, Inc.
- Mosquito saliva protein malaria vaccine27 Sep 2022US 11,452,769 B2Yale University
- NPP1 Fusion Proteins22 Jan 2026US 2026/0022356 A1Inozyme Pharma, Inc.
- Treatment and Prophylaxis of Amyloidosis28 Aug 2025US 2025/0268999 A1University of Tennessee Research Foundation
- Nutrient intake amount estimation system, nutrient intake amount estimation method, nutrient intake amount estimation device, storage medium, and nutrient intake amount output method12 Jun 2025US 2025/0191731 A1Toto Ltd.
- Systems and methods for improved in vivo analyte sensor function22 May 2025US 2025/0160698 A1Abbott Diabetes Care Inc.
- Antigen binding molecules with increased fc receptor binding affinity and effector function12 Sep 2024US 2024/0301079 A1Roche Glycart AG
Most cited
By later US patents
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Single polypeptide chain binding molecules2,454US 4,946,778 AGenex Corporation · 1990
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Adhesive sealant composition1,238US 5,583,114 AMinnesota Mining and Manufacturing Company · 1996